BioScreening - organic compounds for screening

30.08.2003 August 2003 News Archive

8/19/03 - NicOx
Announced an agreement with Merck to evaluate selected nitric oxide-donating compounds under NicOx’s intellectual property rights. NicOx will provide Merck with nitric oxide-donating compounds for evaluation in a preclinical testing program in an undisclosed therapeutic area. A joint research group will coordinate the research program. 

8/18/03 - ChemCodes/VM Discovery
Established a strategic alliance that provides access to and leverages each firm's technologies to increase molecular diversity, accuracy and speed of small molecule drug discovery. The alliance will be used for ChemCodes' internal drug discovery programs, respective corporate partnership collaborations and for joint pursuit of selected drug discovery programs. 

8/14/03 - Pierce Biotechnology/Amphioxus Cell Technologies
Entered into a co-marketing agreement involving two complementary platform technologies used in high-throughput drug discovery. both companies will co-market products used in target identification and validation specific to kinases, phosphatases and ADME-TOX. The companies will share specific product information and support enabling the technologies to remain compatible.

8/12/03 - Argonaut Technologies
Announced introduction of a new technology that combines the effectiveness of Argonaut's resins with specially designed cartridges that improve yield and accelerate purification. Specifically, the MP-TsOH cartridges provide drug discovery and medicinal chemists with a means to increase the purification throughput of amines, an important class of drug compounds.

8/12/03 - Tecan
Launched several new automation solutions at Drug Discovery Technology 2003, in Boston. Tecan showcased additional new automation technologies including Freedom EVO, a powerful, flexible and scalable platform, and an animated video presentation of its corresponding control management software, Freedom EVOware. In addition, Tecan unveiled GENios Pro with injectors, a cost-effective multimode microplate reader that made its U.S. debut.

8/11/03 - Norak Biosciences/Cellomics
Norak Biosciences, Inc., a global leader in the discovery and development of drugs that regulate GPCRs), and Cellomics, Inc., the leading provider of integrated platforms for drug discovery focused on understanding the functions and effectors of living cells, signed a N American/European sales and marketing agreement. The agreement additionally provides for 1) marketing of Norak's Transfluor® technology with Cellomics' ArrayScan® HCS Reader and/or KineticScan® HCS Reader; and 2) co-development of future GPCR- based reagent products. 

8/11/03 - Tripos
Announced the release of ChemCoreRIOTM, ChemCoreREGTM and the Tripos Electronic NotebookTM, the key components in its new informatics solution designed to streamline laboratory workflows, and SARNavigatorTM and LITHIUMTM, the data analysis and decision support components in its knowledge management solution. The key to the success of the system is the AuspyxTM data cartridge, which enables Oracle to process chemical structures like any other pieces of data.

8/11/03 - Genetix
The aliQuot is a new purpose built low-volume liquid dispensing system. The aliQuot allows dispensing into 96-, 384- and 1536-well microplates including Genetix low profile, standard height and deep-well microplates in the 0.5-10 μl range. A range of interchangeable reagent reservoirs, ranging from 60 ml to 2 liters in volume, are available. 

8/5/03 - Norak
Announced acquisition from LION bioscience AG of the ChemFolio® library of > 500,000 diverse compounds originally acquired by Lion through its 2001 acquisition of Trega Biosciences of San Diego. Trega has sold various ChemFolio sub-libraries to more than twenty pharmaceutical and biotechnology companies worldwide. 
8/1/03 - NiKem Research
Has entered into further research collaborations with GlaxoSmithKline, following the successful completion of a lead optimization project. The two new research agreements enable GSK Psychiatry and GSK Neurology & GI CEDD to access NiKem's chemitechnology platform and medicinal chemists for the creation of focused combinatorial libraries and support in medicinal chemistry with NiKem's Fast-Track Hit Validation and Lead Optimization Plus services. 

new | january 2008 | october 2007 | september 2007 | august 2007 | march 2007 | february 2007 | january 2007 | december 2007 | september 2006 | august 2006 | july 2006 | june 2006 | may 2006 | april 2006 | march 2006 | january 2006 | november 2005 | august 2005 | july 2005 | june 2005 | may 2005 | april 2005 | march 2005 | december 2005 | november 2004 | october 2004 | september 2004 | august 2004 | july 2004 | june 2004 | may 2004 | april 2004 | march 2004 | february 2004 | january 2004 | december 2004 | november 2003 | october 2003 | september 2003 | august 2003 | july 2003 | june 2003 | may 2003